Brokerages Set $8.00 Price Target for Applied DNA Sciences Inc (NASDAQ:APDN)

Share on StockTwits

Applied DNA Sciences Inc (NASDAQ:APDN) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating. Applied DNA Sciences’ rating score has improved by 66.7% from 90 days ago as a result of various analysts’ upgrades and downgrades.

Brokerages have set a one year consensus price target of $8.00 for the company, according to Zacks. Zacks has also given Applied DNA Sciences an industry rank of 100 out of 255 based on the ratings given to related companies.

APDN has been the subject of several research reports. ValuEngine raised Applied DNA Sciences from a “hold” rating to a “buy” rating in a report on Tuesday. Maxim Group reiterated a “buy” rating and set a $8.00 target price on shares of Applied DNA Sciences in a research report on Wednesday.

In other Applied DNA Sciences news, insider William W. Montgomery acquired 75,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The shares were acquired at an average cost of $5.24 per share, for a total transaction of $393,000.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 22.42% of the company’s stock.

An institutional investor recently bought a new position in Applied DNA Sciences stock. Wells Fargo & Company MN acquired a new position in shares of Applied DNA Sciences Inc (NASDAQ:APDN) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 108,773 shares of the technology company’s stock, valued at approximately $54,000. Wells Fargo & Company MN owned approximately 0.30% of Applied DNA Sciences at the end of the most recent reporting period.

Shares of NASDAQ:APDN traded up $0.12 during trading on Friday, hitting $3.94. 127,243 shares of the stock were exchanged, compared to its average volume of 133,211. The company has a fifty day moving average price of $3.63 and a two-hundred day moving average price of $1.20. Applied DNA Sciences has a 12-month low of $3.70 and a 12-month high of $46.60.

About Applied DNA Sciences

Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.

Further Reading: What are the reasons investors use put options?

Get a free copy of the Zacks research report on Applied DNA Sciences (APDN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

QuickLogic  Downgraded by Zacks Investment Research to Sell
QuickLogic Downgraded by Zacks Investment Research to Sell
Regeneron Pharmaceuticals  Upgraded to “Buy” by BidaskClub
Regeneron Pharmaceuticals Upgraded to “Buy” by BidaskClub
Proofpoint  Raised to “Buy” at BidaskClub
Proofpoint Raised to “Buy” at BidaskClub
Omeros  Upgraded at BidaskClub
Omeros Upgraded at BidaskClub
360 Finance  Rating Increased to Buy at ValuEngine
360 Finance Rating Increased to Buy at ValuEngine
Kiniksa Pharmaceuticals  Downgraded by Zacks Investment Research to “Sell”
Kiniksa Pharmaceuticals Downgraded by Zacks Investment Research to “Sell”


 
© 2006-2020 Zolmax.